Bowel diseases Etrolizumab IND Filgotinib IND Mirikizumab Ozanimod IND Risankizumab IND Teduglutide IND Upadacitinib Rinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. IND Moderately to Severely Active Crohns disease IND Vedolizumab IND Other chronic immune diseases Adrenaline Arachis hypogaea (pinda) allergenen (pleister) Avacopan Avapritinib IND Baricitinib Systemic lupus erythematosus IND Extension of indication to include treatment of severe alopecia areata in adult patients for Olumiant. IND Berotralstat Budesonide modified released capsule IND Canakinumab IND Coacillium topical Dupilumab IND FCR 001 Icatibant G Mavorixafor OTL 103 RP-L201 Sizavaleucel Sutimlimab Voclosporin Vonoprazan Rheumatism Anifrolumab Cyclobenzaprine hydrochloride Risankizumab IND Sarilumab IND Secukinumab Extension of indication to include treatment of Juvenile Idiopathic Arthritis (Enthesitis Related Arthritis and Juvenile Psoriatic Arthritis) in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. IND Extension of indication to include treatment of Juvenile Idiopathic Arthritis (Enthesitis Related Arthritis and Juvenile Psoriatic Arthritis) in patients 2 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. IND Tofacitinib IND Upadacitinib IND Skin diseases Abrocitinib Beremagene geperpavec Berkenschorsextract Deucravacitinib Difelikefalin Dupilumab Dupixent is geïndiceerd bij kinderen van 6 maanden tot 6 jaar met ernstige atopische dermatitis die in aanmerking komen voor systemische behandeling. IND Dupixent is geïndiceerd bij volwassenen voor de behandeling van Prurigo Nodularis die onvoldoende onder controle zijn met topische behandelingen, of wanneer deze behandelingen niet gepast zijn. IND Lebrikizumab Ligelizumab Regenerative Skin Tissue Roflumilast topical Ruxolitinib phosphate Secukinumab IND Spesolimab Tapinarof Adult Plaque Psoriasis Atopische dermatitis Tirbanibulin Tralokinumab IND Unknown Olopatadine / mometasone